Trial Profile
An Open-Label Drug-Drug Interaction Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone (JNJ-589485) Following Administration of Abiraterone Acetate (JNJ-212082) Tablets in Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2015
Price :
$35
*
At a glance
- Drugs Abiraterone acetate (Primary) ; Ketoconazole
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 08 May 2012 New trial record